📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CV Therapeutics

1.1 - Company Overview

CV Therapeutics Logo

CV Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of research-based biopharmaceutical drugs for cardiovascular diseases, particularly angina pectoris, serving the U.S. healthcare industry. The company researches and manufactures cardiovascular drugs and developed Ranexa for chronic angina.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CV Therapeutics

Angiolink Logo

Angiolink

HQ: United States Website
  • Description: Provider of vascular closure solutions for catheter-based procedures, offering the EVS vascular closure system, an arterial stapling device designed to close holes and punctures in arteries following procedures such as angioplasty and angiograms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Angiolink company profile →
AtheroGenics Logo

AtheroGenics

HQ: United States Website
  • Description: Provider of pharmaceutical solutions focused on developing antioxidants.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AtheroGenics company profile →
Lamed Logo

Lamed

HQ: Germany Website
  • Description: Provider of a vascular and cardiovascular product market access platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lamed company profile →
Jotec Logo

Jotec

HQ: Germany Website
  • Description: Provider of medical devices for aortic and peripheral vascular disease, offering conventional vascular grafts and interventional stent graft implants for vascular and cardiac surgery and radiology/cardiology. Portfolio includes custom-made and off-the-shelf multibranch systems for aortic arch, thoracic and thoracoabdominal aneurysms, with features for secure fixation, optimized flow, visibility, reduced procedure time, and sealing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jotec company profile →
Capricor Logo

Capricor

HQ: United States Website
  • Description: Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Capricor company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CV Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CV Therapeutics

2.2 - Growth funds investing in similar companies to CV Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CV Therapeutics

4.2 - Public trading comparable groups for CV Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CV Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CV Therapeutics

What does CV Therapeutics do?

CV Therapeutics is a provider of research-based biopharmaceutical drugs for cardiovascular diseases, particularly angina pectoris, serving the U.S. healthcare industry. The company researches and manufactures cardiovascular drugs and developed Ranexa for chronic angina.

Who are CV Therapeutics's competitors?

CV Therapeutics's competitors and similar companies include Angiolink, AtheroGenics, Lamed, Jotec, and Capricor.

Where is CV Therapeutics headquartered?

CV Therapeutics is headquartered in United States.

How many employees does CV Therapeutics have?

CV Therapeutics has 1,000 employees 🔒.

When was CV Therapeutics founded?

CV Therapeutics was founded in 2010 🔒.

What sector and industry vertical is CV Therapeutics in?

CV Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CV Therapeutics

Who are the top strategic acquirers in CV Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in CV Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CV Therapeutics?

Top strategic M&A buyers groups and sectors for CV Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CV Therapeutics's sector and industry vertical

Which are the top PE firms investing in CV Therapeutics's sector and industry vertical?

Top PE firms investing in CV Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CV Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CV Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CV Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CV Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CV Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CV Therapeutics?

The key public trading comparables and valuation benchmarks for CV Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CV Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CV Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CV Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CV Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CV Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in CV Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CV Therapeutics